Filing Details

Accession Number:
0001209191-17-031159
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-05-10 12:52:21
Reporting Period:
2017-05-09
Filing Date:
2017-05-10
Accepted Time:
2017-05-10 12:52:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1510580 Kite Pharma Inc. KITE Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1569002 B Steven Ruchefsky C/O Kite Pharma, Inc.
2225 Colorado Avenue
Santa Monica CA 90404
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-05-09 1,400 $69.50 225,426 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Includes 136,038 shares, previously registered in the name of Commercial Street Capital, LLC, which were distributed to the Reporting Person on April 3, 2017 in a pro rata distribution and are now owned directly.